NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · Real-Time Price · USD
2.250
-0.090 (-3.85%)
At close: Aug 21, 2025, 4:00 PM
2.230
-0.020 (-0.89%)
After-hours: Aug 21, 2025, 7:12 PM EDT
NEXGEL Revenue
NEXGEL had revenue of $2.88M in the quarter ending June 30, 2025, with 100.28% growth. This brings the company's revenue in the last twelve months to $11.67M, up 133.02% year-over-year. In the year 2024, NEXGEL had annual revenue of $8.69M with 112.47% growth.
Revenue (ttm)
$11.67M
Revenue Growth
+133.02%
P/S Ratio
1.46
Revenue / Employee
$614,316
Employees
19
Market Cap
18.15M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.69M | 4.60M | 112.47% |
| Dec 31, 2023 | 4.09M | 2.04M | 99.66% |
| Dec 31, 2022 | 2.05M | 497.00K | 32.04% |
| Dec 31, 2021 | 1.55M | 877.00K | 130.12% |
| Dec 31, 2020 | 674.00K | -43.00K | -6.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
NXGL News
- 9 days ago - NEXGEL, Inc. (NXGL) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - NEXGEL to Report Second Quarter 2025 Financial Results on August 12th - GlobeNewsWire
- 20 days ago - NEXGEL Announces $950,000 Registered Direct Offering and Concurrent Private Placement - GlobeNewsWire
- 5 weeks ago - NEXGEL and STADA AG Announce Expansion of Partnership for North America - GlobeNewsWire
- 3 months ago - NEXGEL, Inc. (NXGL) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - NEXGEL to Report First Quarter 2025 Financial Results on May 13th - GlobeNewsWire
- 5 months ago - NEXGEL, Inc. (NXGL) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - NEXGEL Reports Record Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire